ZRZulqarnain Rashid

Zulqarnain Rashid

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zulqarnain Rashid has a total of 154 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Wearable and Smartphone-Based Sleep Measurement in Autistic and Nonautistic Smartphone Users: Longitudinal Observational Study (Preprint)

    by Akash Roy Choudhury, Isabel Yorke, Charlotte Boatman, Bethany Oakley, Mei Lin Law, Rosemary Holt, Laura Colomar Molla, Natalie J Forde, Pauline Conde, Heet Sankesara, et al.

    BACKGROUND Sleep problems are common among autistic individuals; however, reliable sleep assessment methods suitable for everyday life are lacking. Remote measurement technologies (RMT), including wearable sensors, passive smartphone data, and brief active self-reports, offer low-burden, scalable approaches. However, their feasibility has not been investigated in autistic adolescents and adults. OBJECTIVE This study assessed the feasibility of a 28-day multimodal RMT protocol for sleep measurement in autistic and nonautistic participants, examined differences in passive sleep features and active sleep quality scores between groups, and explored associations between them. METHODS Autistic and nonautistic participants, aged 14-35 years, completed a 28-day multimodal observation protocol involving Fitbit devices, RADAR-base passive sensing and active reporting apps. Passive sleep features were extracted using Fitbit sleep staging and steps, and smartphone accelerometer, ambient light, and app usage data. The features comprised sleep onset and offset time, sleep preparation period, wake after sleep onset, number of awakenings, latency to arising, total sleep time, sleep efficiency, and sleep-stage proportions. The feasibility assessment considered modality-specific data availability and the number of eligible analysis days (defined as those with both an identifiable primary sleep period and a sleep quality score) and examined correlations with participant characteristics. Linear mixed-effects regression models evaluated group differences and correlations between passive measures and active sleep quality scores. We used agglomerative clustering to explore whether nights could be meaningfully grouped based on passive sleep features, and whether these groups associated with active reports. RESULTS Feasibility analyses were based on 34 autistic and 39 nonautistic participants who enrolled in the study. Median Fitbit wear time, passive smartphone data availability, and active sleep rating availability were similar across groups and exceeded 75%. However, only 447 of 952 autistic participant-days (47.0%) and 645 of 1092 nonautistic participant-days (59.1%) were usable. Among autistic participants, greater tactile sensitivity was associated with lower availability of the primary sleep period and fewer eligible days. Autistic participants reported lower sleep quality than nonautistic participants (β = .447, P = .011), had shorter total sleep time (β = .408, P = .005), and had shorter sleep preparation periods (β = .444, P = .005). In both groups, higher sleep efficiency, longer total sleep duration, greater proportion of REM sleep, and later sleep offset time were associated with higher sleep quality ratings. Agglomerative clustering yielded three passive sleep feature profiles associated with significantly different active ratings. CONCLUSIONS This study demonstrates favourable feasibility of multimodal RMT sleep assessment for most autistic and nonautistic participants, whilst also identifying specific challenges for some. Passive sleep features and derived profiles corresponded with active daily sleep quality ratings, supporting their utility for further refinement and adaptation in pursuit of low-burden, ecologically valid sleep assessment for autistic populations. INTERNATIONAL REGISTERED REPORT RR2-10.2196/71145

  • Real-Time Mobile Health Analytics and Interventions Pipeline to Detect Acute Events in COPD

    by Heet Sankesara, Yatharth Ranjan, Pauline Conde, Malik Althobiani, Zulqarnain Rashid, Akash Roy Choudhury, Callum Stewart, Yuezhou Zhang, Joanna Porter, John Hurst, et al.

  • Open Access

    Participant Engagement and Data Compliance in Remote Digital Studies for ADHD, Autism, and Eating Disorders

    by Heet Sankesara, Pauline Conde, Yatharth Ranjan, Isabel Yorke, Alice Barnes, Ulrike Schmidt, Richard Jb Dobson, Amos A Folarin, Zulqarnain Rashid

  • Open Access

    A Dual In-Person and Remote Assessment Approach to Developing Digital End Points Relevant to Autism and Co-Occurring Conditions: Protocol for a Multisite Observational Study

    by Isabel Yorke, Charlotte A Boatman, Akash Roy Choudhury, Bethany Oakley, Pauline Conde, Heet Sankesara, Yatharth Ranjan, Zulqarnain Rashid, Judith Dineley, Johnny Downs, et al.

    Background: Research priorities for autistic people include developing effective interventions for the numerous challenges affecting their daily living, for example, mental health problems, sleep difficulties, and social well-being. However, clinical research progress is limited by a lack of validated objective measures that represent target outcomes for improvement. Digital technologies, including wearable devices and smartphone apps, provide opportunities to develop novel measures that may reflect everyday experience and complement key clinical assessments. However, little is known about the acceptability and feasibility of implementing digital data collection in this population. Objective: The primary objective of this study is to evaluate the usability, acceptability, adherence, and feasibility of a dual in-person and remote (ie, at-home) protocol. Secondarily, we aim to explore the properties of certain resulting data with a view to developing novel digital end points for key target outcomes, including social communication, sleep, and mental health. Methods: Eligible autistic and nonautistic in the AIMS Longitudinal European Autism Project were invited to participate in a digitally augmented in-person Autism Diagnostic Observation Schedule-2 (ADOS-2) and a 28-day remote measurement (RM) protocol involving wearing a Fitbit device, downloading a passive smartphone data collection app, and using 2 active reporting apps. Results: The first AIMS Longitudinal European Autism Project study participants were enrolled in September 2021 (in-person component) and March 2022 (RM component). To date, 190 participants have taken part in the digitally augmented ADOS-2 component, and 86 participants have been enrolled for the RM protocol. Recruitment is now complete with some RM data collection ongoing until August 2025. Data analysis has commenced, including qualitative framework analysis of feedback interview data coproduced with autism community members, exploration of acceptability and feasibility metrics, pipeline development for ADOS-2 speech analysis, and RM sleep measures. Conclusions: This study lays important groundwork in understanding the acceptability and feasibility of in-person and remotely implemented digital measurement procedures to capture meaningful outcomes in domains important to improving everyday life for autistic people. International Registered Report Identifier (IRRID): DERR1-10.2196/71145


  • Open Access

    Identifying Digital Markers of Attention-Deficit/Hyperactivity Disorder (ADHD) in a Remote Monitoring Setting: Prospective Observational Study

    by Heet Sankesara, Hayley Denyer, Shaoxiong Sun, Qigang Deng, Yatharth Ranjan, Pauline Conde, Zulqarnain Rashid, Philip Asherson, Andrea Bilbow, Madeleine J Groom, et al.

    Background: The symptoms and associated characteristics of attention-deficit/hyperactivity disorder (ADHD) are typically assessed in person at a clinic or in a research lab. Mobile health offers a new approach to obtaining additional passively and continuously measured real-world behavioral data. Using our new ADHD remote technology (ART) system, based on the Remote Assessment of Disease and Relapses (RADAR)–base platform, we explore novel digital markers for their potential to identify behavioral patterns associated with ADHD. The RADAR-base Passive App and wearable device collect sensor data in the background, while the Active App involves participants completing clinical symptom questionnaires. Objective: The main aim of this study was to investigate whether adults and adolescents with ADHD differ from individuals without ADHD on 10 digital signals that we hypothesize capture lapses in attention, restlessness, or impulsive behaviors. Methods: We collected data over 10 weeks from 20 individuals with ADHD and 20 comparison participants without ADHD between the ages of 16 and 39 years. We focus on features derived from (1) Active App (mean and SD of questionnaire notification response latency and of the time interval between questionnaires), (2) Passive App (daily mean and SD of response time to social and communication app notifications, the SD in ambient light during phone use, total phone use time, and total number of new apps added), and (3) a wearable device (Fitbit) (daily steps taken while active on the phone). Linear mixed models and t tests were employed to assess the group differences for repeatedly measured and time-aggregated variables, respectively. Effect sizes ( d ) convey the magnitude of differences. Results: Group differences were significant for 5 of the 10 variables. The participants with ADHD were (1) slower ( P =.047, d =1.05) and more variable ( P =.01, d =0.84) in their speed of responding to the notifications to complete the questionnaires, (2) had a higher SD in the time interval between questionnaires ( P =.04, d =1.13), (3) had higher daily mean response time to social and communication app notifications ( P =.03, d =0.7), and (4) had a greater change in ambient (background) light when they were actively using the smartphone ( P =.008, d =0.86). Moderate to high effect sizes with nonsignificant P values were additionally observed for the mean of time intervals between questionnaires ( P =.06, d =0.82), daily SD in responding to social and communication app notifications ( P =.05, d =0.64), and steps taken while active on the phone ( P =.09, d =0.61). The groups did not differ in the total phone use time ( P =.11, d =0.54) and the number of new apps downloaded ( P =.24, d =0.18). Conclusions: In a novel exploration of digital markers of ADHD, we identified candidate digital signals of restlessness, inconsistent attention, and difficulties completing tasks. Larger future studies are needed to replicate these findings and to assess the potential of such objective digital signals for tracking ADHD severity or predicting outcomes.


  • Open Access

    A Dual In-Person and Remote Assessment Approach to Developing Digital End Points Relevant to Autism and Co-Occurring Conditions: Protocol for a Multisite Observational Study (Preprint)

    by Isabel Yorke, Charlotte A Boatman, Akash Roy Choudhury, Bethany Oakley, Pauline Conde, Heet Sankesara, Yatharth Ranjan, Zulqarnain Rashid, Judith Dineley, Johnny Downs, et al.

    BACKGROUND Research priorities for autistic people include developing effective interventions for the numerous challenges affecting their daily living, for example, mental health problems, sleep difficulties, and social well-being. However, clinical research progress is limited by a lack of validated objective measures that represent target outcomes for improvement. Digital technologies, including wearable devices and smartphone apps, provide opportunities to develop novel measures that may reflect everyday experience and complement key clinical assessments. However, little is known about the acceptability and feasibility of implementing digital data collection in this population. OBJECTIVE The primary objective of this study is to evaluate the usability, acceptability, adherence, and feasibility of a dual in-person and remote (ie, at-home) protocol. Secondarily, we aim to explore the properties of certain resulting data with a view to developing novel digital end points for key target outcomes, including social communication, sleep, and mental health. METHODS Eligible autistic and nonautistic in the AIMS Longitudinal European Autism Project were invited to participate in a digitally augmented in-person Autism Diagnostic Observation Schedule-2 (ADOS-2) and a 28-day remote measurement (RM) protocol involving wearing a Fitbit device, downloading a passive smartphone data collection app, and using 2 active reporting apps. RESULTS The first AIMS Longitudinal European Autism Project study participants were enrolled in September 2021 (in-person component) and March 2022 (RM component). To date, 190 participants have taken part in the digitally augmented ADOS-2 component, and 86 participants have been enrolled for the RM protocol. Recruitment is now complete with some RM data collection ongoing until August 2025. Data analysis has commenced, including qualitative framework analysis of feedback interview data coproduced with autism community members, exploration of acceptability and feasibility metrics, pipeline development for ADOS-2 speech analysis, and RM sleep measures. CONCLUSIONS This study lays important groundwork in understanding the acceptability and feasibility of in-person and remotely implemented digital measurement procedures to capture meaningful outcomes in domains important to improving everyday life for autistic people. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/71145

  • Open Access

    Digital Phenotyping of Mental and Physical Conditions: Remote Monitoring of Patients Through RADAR-Base Platform

    by Zulqarnain Rashid, Zulqarnain Rashid, Amos A Folarin, Amos A Folarin, Yuezhou Zhang, Yuezhou Zhang, Yatharth Ranjan, Yatharth Ranjan, Pauline Conde, Pauline Conde, et al.

    Background: The use of digital biomarkers through remote patient monitoring offers valuable and timely insights into a patient’s condition, including aspects such as disease progression and treatment response. This serves as a complementary resource to traditional health care settings leveraging mobile technology to improve scale and lower latency, cost, and burden. Objective: Smartphones with embedded and connected sensors have immense potential for improving health care through various apps and mobile health (mHealth) platforms. This capability could enable the development of reliable digital biomarkers from long-term longitudinal data collected remotely from patients. Methods: We built an open-source platform, RADAR-base, to support large-scale data collection in remote monitoring studies. RADAR-base is a modern remote data collection platform built around Confluent’s Apache Kafka to support scalability, extensibility, security, privacy, and quality of data. It provides support for study design and setup and active (eg, patient-reported outcome measures) and passive (eg, phone sensors, wearable devices, and Internet of Things) remote data collection capabilities with feature generation (eg, behavioral, environmental, and physiological markers). The back end enables secure data transmission and scalable solutions for data storage, management, and data access. Results: The platform has been used to successfully collect longitudinal data for various cohorts in a number of disease areas including multiple sclerosis, depression, epilepsy, attention-deficit/hyperactivity disorder, Alzheimer disease, autism, and lung diseases. Digital biomarkers developed through collected data are providing useful insights into different diseases. Conclusions: RADAR-base offers a contemporary, open-source solution driven by the community for remotely monitoring, collecting data, and digitally characterizing both physical and mental health conditions. Clinicians have the ability to enhance their insight through the use of digital biomarkers, enabling improved prevention, personalization, and early intervention in the context of disease management.


  • Open Access

    Remote Monitoring of Epilepsy Patients with Wearable Device and Smartphone

    by Zulqarnain Rashid, Akash Roy Choudhury, Amos A Folarin, Yatharth Ranjan, Pauline Conde, Heet Sankesara, Elisa Bruno, Richard Jb Dobson


  • Open Access

    RADAR-IoT: An Open-Source, Interoperable, and Extensible IoT Gateway Framework for Health Research

    by Yatharth Ranjan, Jiangeng Chang, Heet Sankesara, Pauline Conde, Zulqarnain Rashid, Richard J. B. Dobson, Amos Folarin

    IoT sensors offer a wide range of sensing capabilities, many of which have potential health applications. Existing solutions for IoT in healthcare have notable limitations, such as closed-source, limited I/O protocols, limited cloud platform support, and missing specific functionality for health use cases. Developing an open-source internet of things (IoT) gateway solution that addresses these limitations and provides reliability, broad applicability, and utility is highly desirable. Combining a wide range of sensor data streams from IoT devices with ambulatory mHealth data would open up the potential to provide a detailed 360-degree view of the relationship between patient physiology, behavior, and environment. We have developed RADAR-IoT as an open-source IoT gateway framework, to harness this potential. It aims to connect multiple IoT devices at the edge, perform limited on-device data processing and analysis, and integrate with cloud-based mobile health platforms, such as RADAR-base, enabling real-time data processing. We also present a proof-of-concept data collection from this framework, using prototype hardware in two locations. The RADAR-IoT framework, combined with the RADAR-base mHealth platform, provides a comprehensive view of a user’s health and environment by integrating static IoT sensors and wearable devices. Despite its current limitations, it offers a promising open-source solution for health research, with potential applications in managing infection control, monitoring chronic pulmonary disorders, and assisting patients with impaired motor control or cognitive ability.


  • Open Access

    Home monitoring to detect progression of interstitial lung disease: A prospective cohort study

    by Malik A. Althobiani, Yatharth Ranjan, Anne‐Marie Russell, Joseph Jacob, Michele Orini, Heet Sankesara, Pauline Conde, Zulqarnain Rashid, Richard J. B. Dobson, John R. Hurst, et al.